Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CContineum Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Contineum Therapeutics, Inc.

$13.38Close · Oct 9, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 8, 2026Stengone Carmine N.CEO and President2,500Class A Common Stock$41.8KSell
Sep 8, 2026Stengone Carmine N.CEO and President2,500Class A Common Stock$41.8KOption exercise
Aug 3, 2026Stengone Carmine N.CEO and President2,500Class A Common Stock$38.7KSell
Aug 3, 2026Stengone Carmine N.CEO and President2,500Class A Common Stock$38.7KOption exercise
Jul 9, 2026Lorrain Daniel S.Chief Scientific Officer25Class A Common Stock$377.50Sell
Jul 9, 2026Lorrain Daniel S.Chief Scientific Officer25Class A Common Stock$377.50Option exercise
Jul 8, 2026Lorrain Daniel S.Chief Scientific Officer1,015Class A Common Stock$15.3KSell
Jul 8, 2026Lorrain Daniel S.Chief Scientific Officer1,015Class A Common Stock$15.3KOption exercise
Jul 8, 2026Stengone Carmine N.CEO and President2,500Class A Common Stock$37.8KSell
Jul 8, 2026Stengone Carmine N.CEO and President2,500Class A Common Stock$37.8KOption exercise
…